https://stock.noler.com/us/stock/acorda-therapeutics-inc https://stock.noler.com/us/stock/acorda-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/acorda-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/acorda-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/accrued-bonuses-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/accrued-royalties-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/accrued-sales-commission-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/accrued-vacation-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquired-finite-lived-intangible-asset-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisition-consideration-transferred-liabilities-incurred https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisition-contingent-consideration-arrangements-range-of-outcomes-value-high https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisition-contingent-consideration-arrangements-range-of-outcomes-value-low https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/acorda-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/acorda-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/acorda-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/acorda-therapeutics-inc/adjustment-to-additional-paid-in-capital-income-tax-effect-from-share-based-compensation-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/acorda-therapeutics-inc/allowance-for-doubtful-accounts-receivable-charge-offs https://stock.noler.com/us/stock/acorda-therapeutics-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/acorda-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/acorda-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/acorda-therapeutics-inc/amortization https://stock.noler.com/us/stock/acorda-therapeutics-inc/amortization-of-acquired-intangible-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/acorda-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/acorda-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/aoci https://stock.noler.com/us/stock/acorda-therapeutics-inc/area-of-real-estate-property https://stock.noler.com/us/stock/acorda-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/acorda-therapeutics-inc/assets-held-for-sale-long-lived-fair-value-disclosure https://stock.noler.com/us/stock/acorda-therapeutics-inc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/acorda-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/acorda-therapeutics-inc/business-acquisition-contingent-consideration-potential-cash-payment https://stock.noler.com/us/stock/acorda-therapeutics-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/acorda-therapeutics-inc/business-acquisition-cost-of-acquired-entity-liabilities-incurred https://stock.noler.com/us/stock/acorda-therapeutics-inc/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-finished-goods https://stock.noler.com/us/stock/acorda-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/acorda-therapeutics-inc/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/acorda-therapeutics-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/acorda-therapeutics-inc/cash https://stock.noler.com/us/stock/acorda-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/acorda-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/acorda-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/acorda-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/acorda-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/acorda-therapeutics-inc/claims-settled-and-dismissed-number https://stock.noler.com/us/stock/acorda-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/acorda-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/congressional-trades-other https://stock.noler.com/us/stock/acorda-therapeutics-inc/contract-with-customer-asset-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/contractual-obligation https://stock.noler.com/us/stock/acorda-therapeutics-inc/contractual-obligation-due-in-fourth-and-fifth-year https://stock.noler.com/us/stock/acorda-therapeutics-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/acorda-therapeutics-inc/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/acorda-therapeutics-inc/convertible-debt-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/acorda-therapeutics-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/convertible-securities-retired https://stock.noler.com/us/stock/acorda-therapeutics-inc/cost-of-goods-sold https://stock.noler.com/us/stock/acorda-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/acorda-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/acorda-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-convertible-carrying-amount-of-the-equity-component https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-periodic-payment-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/acorda-therapeutics-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-finance-costs-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-revenue-revenue-recognized-1 https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-derivative-instruments https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-alternative-minimum-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-legal-settlements https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-returns-and-allowances https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/acorda-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/acorda-therapeutics-inc/depreciation https://stock.noler.com/us/stock/acorda-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/acorda-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/acorda-therapeutics-inc/dilutive-securities https://stock.noler.com/us/stock/acorda-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/acorda-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/acorda-therapeutics-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/acorda-therapeutics-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/acorda-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/acorda-therapeutics-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/acorda-therapeutics-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/embedded-derivative-loss-on-embedded-derivative https://stock.noler.com/us/stock/acorda-therapeutics-inc/embedded-derivative-no-longer-bifurcated-amount-reclassified-to-stockholders-equity https://stock.noler.com/us/stock/acorda-therapeutics-inc/eps https://stock.noler.com/us/stock/acorda-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/acorda-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/acorda-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/acorda-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/acorda-therapeutics-inc/fair-value-liabilities-change-in-unrealized-gain-loss-included-in-other-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/fair-value-liabilities-obligations https://stock.noler.com/us/stock/acorda-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-future-amortization-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/acorda-therapeutics-inc/foreign-currency-transaction-gain-loss-realized https://stock.noler.com/us/stock/acorda-therapeutics-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/acorda-therapeutics-inc/future-amortization-expense-year-five https://stock.noler.com/us/stock/acorda-therapeutics-inc/future-amortization-expense-year-four https://stock.noler.com/us/stock/acorda-therapeutics-inc/future-amortization-expense-year-one https://stock.noler.com/us/stock/acorda-therapeutics-inc/future-amortization-expense-year-three https://stock.noler.com/us/stock/acorda-therapeutics-inc/future-amortization-expense-year-two https://stock.noler.com/us/stock/acorda-therapeutics-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/acorda-therapeutics-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/acorda-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/goodwill https://stock.noler.com/us/stock/acorda-therapeutics-inc/goodwill-acquired https://stock.noler.com/us/stock/acorda-therapeutics-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/acorda-therapeutics-inc/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/acorda-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/acorda-therapeutics-inc/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/acorda-therapeutics-inc/goodwill-translation-adjustments https://stock.noler.com/us/stock/acorda-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/acorda-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/acorda-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/acorda-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/acorda-therapeutics-inc/impairment-of-investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/income-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/acorda-therapeutics-inc/income-tax-effects-allocated-directly-to-equity-equity-transactions https://stock.noler.com/us/stock/acorda-therapeutics-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/income-tax-receivable https://stock.noler.com/us/stock/acorda-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-commodity-contract-assets-and-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-finished-goods-and-work-in-process-inventories https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/acorda-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/acorda-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/acorda-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/acorda-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/acorda-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/acorda-therapeutics-inc/insider-transactions-stock-units/sales https://stock.noler.com/us/stock/acorda-therapeutics-inc/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/acorda-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/acorda-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/acorda-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/inventory https://stock.noler.com/us/stock/acorda-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/acorda-therapeutics-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/acorda-therapeutics-inc/inventory-raw-materials https://stock.noler.com/us/stock/acorda-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/acorda-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/acorda-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/acorda-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/acorda-therapeutics-inc/liability-for-uncertain-tax-positions-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/license-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/acorda-therapeutics-inc/litigation-reserve https://stock.noler.com/us/stock/acorda-therapeutics-inc/loans-payable-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/long-term-debt-fair-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/long-term-loans-payable https://stock.noler.com/us/stock/acorda-therapeutics-inc/minority-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/minority-interest-decrease-from-redemptions https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-cash-from https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/acorda-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/acorda-therapeutics-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-adoption-quantification https://stock.noler.com/us/stock/acorda-therapeutics-inc/new-claims-filed-number https://stock.noler.com/us/stock/acorda-therapeutics-inc/noncontrolling-interest-increase-from-business-combination https://stock.noler.com/us/stock/acorda-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/acorda-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-before-reclassifications-net-of-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-net-of-tax-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-in-four-and-five-years https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/acorda-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-deferred-credits-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-income-2 https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-inventory https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-operating-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/acorda-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/acorda-therapeutics-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/paid-in-capital-equity-component-of-convertible-debt-subsequent-adjustments https://stock.noler.com/us/stock/acorda-therapeutics-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/acorda-therapeutics-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/acorda-therapeutics-inc/paid-in-capital-stock-split https://stock.noler.com/us/stock/acorda-therapeutics-inc/patents-active https://stock.noler.com/us/stock/acorda-therapeutics-inc/patents-rejected https://stock.noler.com/us/stock/acorda-therapeutics-inc/payments-for-previous-acquisition https://stock.noler.com/us/stock/acorda-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/acorda-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/payments-to-minority-shareholders https://stock.noler.com/us/stock/acorda-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/acorda-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/acorda-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/acorda-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/acorda-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/acorda-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/acorda-therapeutics-inc/proceeds-from-payments-to-minority-shareholders https://stock.noler.com/us/stock/acorda-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/acorda-therapeutics-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/acorda-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/property-plant-and-equipment-useful-life-maximum https://stock.noler.com/us/stock/acorda-therapeutics-inc/property-plant-and-equipment-useful-life-minimum https://stock.noler.com/us/stock/acorda-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/acorda-therapeutics-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/acorda-therapeutics-inc/provision-for-other-credit-losses https://stock.noler.com/us/stock/acorda-therapeutics-inc/public-float https://stock.noler.com/us/stock/acorda-therapeutics-inc/purchase-obligation https://stock.noler.com/us/stock/acorda-therapeutics-inc/purchase-obligation-due-in-fourth-and-fifth-year https://stock.noler.com/us/stock/acorda-therapeutics-inc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/acorda-therapeutics-inc/purchase-obligation-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/acorda-therapeutics-inc/reclassification-from-accumulated-oci-current-period-before-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/acorda-therapeutics-inc/reclassification-from-aoci-current-period-net-of-tax-attributable-to-parent https://stock.noler.com/us/stock/acorda-therapeutics-inc/recognition-of-deferred-revenue https://stock.noler.com/us/stock/acorda-therapeutics-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/repayments-of-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/acorda-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/acorda-therapeutics-inc/research-and-development-in-process https://stock.noler.com/us/stock/acorda-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/acorda-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/acorda-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/restricted-cash-current https://stock.noler.com/us/stock/acorda-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/acorda-therapeutics-inc/restructuring-and-related-cost-expected-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/acorda-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/acorda-therapeutics-inc/restructuring-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/acorda-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/acorda-therapeutics-inc/revenue https://stock.noler.com/us/stock/acorda-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/acorda-therapeutics-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/acorda-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/acorda-therapeutics-inc/royalty-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/royalty-revenue https://stock.noler.com/us/stock/acorda-therapeutics-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-15-12g https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/acorda-therapeutics-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/acorda-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/acorda-therapeutics-inc/severance-costs https://stock.noler.com/us/stock/acorda-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/acorda-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/acorda-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/acorda-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-remaining-term https://stock.noler.com/us/stock/acorda-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/acorda-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/acorda-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/acorda-therapeutics-inc/shares-subject-to-mandatory-redemption-settlement-terms-maximum-number-of-shares https://stock.noler.com/us/stock/acorda-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/acorda-therapeutics-inc/short-term-lease-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-compensation-unrecognized-cost-recognition-period https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-remaining-term https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-remaining-term https://stock.noler.com/us/stock/acorda-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/acorda-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/acorda-therapeutics-inc/subsequent-event-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-benefit-from-stock-options-exercised https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-cuts-and-jobs-act-change-in-tax-rate-income-tax-expense-benefit https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-gilti-percent https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-reconciliation-deductions-other https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/acorda-therapeutics-inc/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/acorda-therapeutics-inc/total-assets https://stock.noler.com/us/stock/acorda-therapeutics-inc/total-contract-liability https://stock.noler.com/us/stock/acorda-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/acorda-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/acorda-therapeutics-inc/treasury-stock-acquired-average-cost-per-share https://stock.noler.com/us/stock/acorda-therapeutics-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/acorda-therapeutics-inc/treasury-stock-shares https://stock.noler.com/us/stock/acorda-therapeutics-inc/treasury-stock-value https://stock.noler.com/us/stock/acorda-therapeutics-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/acorda-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/acorda-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/acorda-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/acorda-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/acorda-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/acorda-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/acorda-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted